Topical ASP-1001 (Contrast Media Formulation) and the Acute Response to Nasal Allergen Challenge (NAC)
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see whether ASP-1001 when given as a nasal spray is safe and
can reduce the signs and symptoms of allergic rhinitis (hayfever) following nasal challenge
with antigen.